Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-11-010224)

Filing Details

Accession Number:: 0001179110-11-010224
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-06-30 09:29:48
Reporting Period:: 2009-06-29

Filing Date:: 2011-06-30
Accepted Time:: 2011-06-30 09:29:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
855654	Immunogen Inc	IMGN	Pharmaceutical Preparations (2834)	042726691

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236371	D Gregory Perry	C/O Immunogen, Inc. 830 Winter Street Waltham MA 02451	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-06-29	8,333	$4.32	8,333	No	4	M	Direct
Common Stock	Disposition	2011-06-29	8,333	$12.07	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2011-06-29	8,333	$4.32	8,333	$4.32

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
116,667	2010-01-09	2019-01-09	No	4	M	Direct

Footnotes

Exercisable as to 31,250 shares commencing on January 9, 2010, and as to 7,812.5 shares on each April 9th, July 9th, October 9th, and January 9th thereafter, beginning on April 9, 2010.
Average price of shares sold.
The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on May 23, 2011.